Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
2(50.0%)
N/A
2(50.0%)
4Total
Phase 2(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00897975Phase 2Completed

Red Yeast Rice and Phytosterols In Statin Intolerance

Role: lead

NCT00639223Phase 2Completed

Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance

Role: collaborator

NCT00405769Not ApplicableCompleted

Lipid Lowering in Patients With Statin Intolerance

Role: lead

NCT00365742Not ApplicableCompleted

Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements

Role: lead

All 4 trials loaded